159 related articles for article (PubMed ID: 24871581)
1. Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination.
Ahlén G; Holmström F; Gibbs A; Alheim M; Frelin L
Gene Ther; 2014 Aug; 21(8):739-50. PubMed ID: 24871581
[TBL] [Abstract][Full Text] [Related]
2. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
Frelin L; Ahlén G; Alheim M; Weiland O; Barnfield C; Liljeström P; Sällberg M
Gene Ther; 2004 Mar; 11(6):522-33. PubMed ID: 14999224
[TBL] [Abstract][Full Text] [Related]
3. A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
Levander S; Sällberg M; Ahlén G; Frelin L
Vaccine; 2016 May; 34(25):2821-33. PubMed ID: 27109565
[TBL] [Abstract][Full Text] [Related]
4. Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo.
Frelin L; Alheim M; Chen A; Söderholm J; Rozell B; Barnfield C; Liljeström P; Sällberg M
Gene Ther; 2003 Apr; 10(8):686-99. PubMed ID: 12692597
[TBL] [Abstract][Full Text] [Related]
5. A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice.
Holmström F; Pasetto A; Nähr V; Brass A; Kriegs M; Hildt E; Broderick KE; Chen M; Ahlén G; Frelin L
J Immunol; 2013 Feb; 190(3):1113-24. PubMed ID: 23284053
[TBL] [Abstract][Full Text] [Related]
6. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
[TBL] [Abstract][Full Text] [Related]
7. In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells.
Ahlén G; Söderholm J; Tjelle T; Kjeken R; Frelin L; Höglund U; Blomberg P; Fons M; Mathiesen I; Sällberg M
J Immunol; 2007 Oct; 179(7):4741-53. PubMed ID: 17878373
[TBL] [Abstract][Full Text] [Related]
8. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
9. Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model.
Levander S; Holmström F; Frelin L; Ahlén G; Rupp D; Long G; Bartenschlager R; Sällberg M
Gut; 2018 Aug; 67(8):1525-1535. PubMed ID: 28646094
[TBL] [Abstract][Full Text] [Related]
10. Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model.
Wedemeyer H; Gagneten S; Davis A; Bartenschlager R; Feinstone S; Rehermann B
Gastroenterology; 2001 Nov; 121(5):1158-66. PubMed ID: 11677208
[TBL] [Abstract][Full Text] [Related]
11. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
[TBL] [Abstract][Full Text] [Related]
12. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles.
Brinster C; Chen M; Boucreux D; Paranhos-Baccala G; Liljeström P; Lemmonier F; Inchauspé G
J Gen Virol; 2002 Feb; 83(Pt 2):369-381. PubMed ID: 11807230
[TBL] [Abstract][Full Text] [Related]
14. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.
Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM
J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843
[TBL] [Abstract][Full Text] [Related]
15. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
16. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
[TBL] [Abstract][Full Text] [Related]
17. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
Gut; 2009 Apr; 58(4):560-9. PubMed ID: 18689426
[TBL] [Abstract][Full Text] [Related]
19. Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.
Chen A; Ahlén G; Brenndörfer ED; Brass A; Holmström F; Chen M; Söderholm J; Milich DR; Frelin L; Sällberg M
J Immunol; 2011 May; 186(9):5107-18. PubMed ID: 21430225
[TBL] [Abstract][Full Text] [Related]
20. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
